다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Trends in cardiovascular medicine, v.30 no.2, 2020년, pp.104 - 112
Sinnenberg, Lauren (Department of Internal Medicine, Brigham and Women's Hospital) , Givertz, Michael M. (Cardiovascular Division, Brigham and Women's Hospital)
AI-Helper
Abstract Acute heart failure (AHF) is one of the most common causes for hospital admission and is associated with a high risk of mortality. Compared to chronic heart failure, there is less robust evidence to guide diagnosis, risk stratification and management of AHF. This state-of-the art review ai...
Eur Heart J Ponikowski 37 27 2129 2016 10.1093/eurheartj/ehw128 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Am J Cardiol Loehr 101 7 1016 2008 10.1016/j.amjcard.2007.11.061 Heart failure incidence and survival (from the atherosclerosis risk in communities study)
Circulation Benjamin 137 12 e67 2018 10.1161/CIR.0000000000000558 Heart disease and stroke statistics-2018 update: A report from the American Heart Association
Donkor A, McDonagh T, Hardman S, National Heart Failure Audit April 2015-March 2016 [Internet]. 2016. Available from: https://www.ucl.ac.uk/nicor/audits/heartfailure/documents/annualreports/annual-report-2015-6-v8.pdf.
Am Heart J Adams 149 2 209 2005 10.1016/j.ahj.2004.08.005 Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)
Circ Cardiovasc Qual Outcomes Krumholz 2 5 407 2009 10.1161/CIRCOUTCOMES.109.883256 Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission
JAMA Desai 316 24 2647 2016 10.1001/jama.2016.18533 Association between hospital penalty status under the hospital readmission reduction program and readmission rates for target and nontarget conditions
JAMA Wadhera 320 24 2542 2018 10.1001/jama.2018.19232 Association of the Hospital Readmissions Reduction Program with mortality among Medicare beneficiaries hospitalized for heart failure, acute myocardial infarction, and pneumonia
J Am Coll Cardiol Abraham 52 5 347 2008 10.1016/j.jacc.2008.04.028 Predictors of in-hospital mortality in patients hospitalized for heart failure
J Am Coll Cardiol Felker 64 15 1591 2014 10.1016/j.jacc.2014.05.071 Effect of serelaxin on mode of death in acute heart failure
N Engl J Med Packer 376 20 1956 2017 10.1056/NEJMoa1601895 Effect of ularitide on cardiovascular mortality in acute heart failure
N Engl J Med O'Connor 365 1 32 2011 10.1056/NEJMoa1100171 Effect of nesiritide in patients with acute decompensated heart failure
Circ Heart Fail Heidenreich 6 3 606 2013 10.1161/HHF.0b013e318291329a Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association
Givertz 281 2013 Cardiovascular Therapeutics: a Companion to Braunwald's Heart Disease Strategies for management of acute decompensated heart failure
J Am Coll Cardiol Tromp 72 10 1081 2018 10.1016/j.jacc.2018.06.050 Identifying pathophysiological mechanisms in heart failure with reduced versus preserved ejection fraction
JACC Heart Fail Tromp 5 7 507 2017 10.1016/j.jchf.2017.04.007 Biomarker profiles of acute heart failure patients with a mid-range ejection fraction
JACC Heart Fail Thibodeau 2 1 24 2014 10.1016/j.jchf.2013.07.009 Characterization of a novel symptom of advanced heart failure: bendopnea
Am J Cardiol Fudim 122 9 1506 2018 10.1016/j.amjcard.2018.07.023 Relation of volume overload to clinical outcomes in acute heart failure (From ASCEND-HF)
J Am Heart Assoc Flint 3 3 2014 10.1161/JAHA.114.000806 B-type natriuretic peptide predicts 30-day readmission for heart failure but not readmission for other causes
Circulation Chow 135 22 2017 10.1161/CIR.0000000000000490 Role of biomarkers for the prevention, assessment, and management of heart failure: a scientific statement from the American Heart Association
J Am Coll Cardiol Ng 69 1 56 2017 10.1016/j.jacc.2016.10.038 Proenkephalin, renal dysfunction, and prognosis in patients with acute heart failure: a GREAT network study
Eur J Heart Fail Demissei 19 8 1001 2017 10.1002/ejhf.749 A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial
Chest Pivetta 148 1 202 2015 10.1378/chest.14-2608 Lung ultrasound-implemented diagnosis of acute decompensated heart failure in the ED: a SIMEU multicenter study
J Am Heart Assoc Simon 7 15 2018 10.1161/JAHA.117.008184 Bedside ultrasound assessment of jugular venous compliance as a potential pointofcare method to predict acute decompensated heart failure 30day readmission
Arch Intern Med Tibaldi 169 17 1569 2009 10.1001/archinternmed.2009.267 Hospital at home for elderly patients with acute decompensation of chronic heart failure
Am Heart J Collins 164 6 825 2012 10.1016/j.ahj.2012.07.033 Risk stratification in acute heart failure: rationale and design of the STRATIFY and DECIDE studies
Circ Heart Fail Fermann 10 2 2017 10.1161/CIRCHEARTFAILURE.116.003581 Design and rationale of a randomized trial of a care transition strategy in patients with acute heart failure discharged from the emergency department: GUIDED-HF (Get With the Guidelines in Emergency Department Patients with Heart Failure)
Pang P., Cole M. Short stay unit vs hospitalization in acute heart failure - full text view - ClinicalTrials.gov. Available from https://clinicaltrials.gov/ct2/show/NCT03302910.
J Am Coll Cardiol Matsue 69 25 3042 2017 10.1016/j.jacc.2017.04.042 Time-to-furosemide treatment and mortality in patients hospitalized with acute heart failure
N Engl J Med Felker 364 9 797 2011 10.1056/NEJMoa1005419 Diuretic strategies in patients with acute decompensated heart failure
JACC Heart Fail Gilotra 6 1 65 2018 10.1016/j.jchf.2017.10.001 Efficacy of intravenous furosemide versus a novel, pH-neutral furosemide formulation administered subcutaneously in outpatients with worsening heart failure
Cardiovasc Ther Moranville 33 2 42 2015 10.1111/1755-5922.12109 Comparison of metolazone versus chlorothiazide in acute decompensated heart failure with diuretic resistance
JACC Heart Fail Sharma 6 10 859 2018 10.1016/j.jchf.2018.04.008 Randomized evaluation of heart failure with preserved ejection fraction patients with acute heart failure and dopamine
J Am Coll Cardiol Felker 69 11 1399 2017 10.1016/j.jacc.2016.09.004 Efficacy and safety of tolvaptan in patients hospitalized with acute heart failure
JAMA Cardiol Butler 2 9 950 2017 10.1001/jamacardio.2017.2198 Efficacy and safety of spironolactone in acute heart failure
JACC Heart Fail Costanzo 4 2 95 2016 10.1016/j.jchf.2015.08.005 Aquapheresis versus intravenous diuretics and hospitalizations for heart failure
JAMA Intern Med Aliti 173 12 1058 2013 10.1001/jamainternmed.2013.552 Aggressive fluid and sodium restriction in acute decompensated heart failure
Circulation Yancy 128 16 e240 2013 2013 ACCF/AHA guideline for the management of heart failure
Lancet Teerlink 381 9860 29 2013 10.1016/S0140-6736(12)61855-8 Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial
JAMA Mebazaa 297 17 1883 2007 10.1001/jama.297.17.1883 Levosimendan vs dobutamine for patients with acute decompensated heart failure
J Am Coll Cardiol Teerlink 67 12 1444 2016 10.1016/j.jacc.2016.01.031 Acute treatment with omecamtiv mecarbil to increase contractility in acute heart failure
N Engl J Med Velazquez 380 6 539 2019 10.1056/NEJMoa1812851 Angiotensin-neprilysin inhibition in acute decompensated heart failure
N Engl J Med Thiele 367 14 1287 2012 10.1056/NEJMoa1208410 Intraaortic balloon support for myocardial infarction with cardiogenic shock
Eur Heart J Thiele 38 47 3523 2017 10.1093/eurheartj/ehx363 Percutaneous short-term active mechanical support devices in cardiogenic shock: a systematic review and collaborative meta-analysis of randomized trials
J Am Coll Cardiol Stretch 64 14 1407 2014 10.1016/j.jacc.2014.07.958 National trends in the utilization of short-term mechanical circulatory support: incidence, outcomes, and cost analysis
J Heart Lung Transplant Hall 37 1 100 2018 10.1016/j.healun.2017.09.020 Use of a percutaneous temporary circulatory support device as a bridge to decision during acute decompensation of advanced heart failure
Heart Park 96 7 533 2010 10.1136/hrt.2009.175257 Potentially detrimental cardiovascular effects of oxygen in patients with chronic left ventricular systolic dysfunction
JAMA Margulies 316 5 500 2016 10.1001/jama.2016.10260 Effects of liraglutide on clinical stability among patients with advanced heart failure and reduced ejection fraction
Circulation Wanner 137 2 119 2018 10.1161/CIRCULATIONAHA.117.028268 Empagliflozin and clinical outcomes in patients with type 2 diabetes mellitus, established cardiovascular disease, and chronic kidney disease
N Engl J Med Anker 361 25 2436 2009 10.1056/NEJMoa0908355 Ferric carboxymaltose in patients with heart failure and iron deficiency
N Engl J Med Zannad 379 14 1332 2018 10.1056/NEJMoa1808848 Rivaroxaban in patients with heart failure, sinus rhythm, and coronary disease
J Card Fail Moser 21 8 612 2015 10.1016/j.cardfail.2015.04.004 Health literacy predicts morbidity and mortality in rural patients with heart failure
Virtual visits in heart failure care transitions - Full Text View - ClinicalTrials.gov. Available from: https://clinicaltrials.gov/ct2/show/NCT03675828.
Am Heart J Reeves 185 130 2017 10.1016/j.ahj.2016.12.012 Rehabilitation therapy in older acute heart failure patients (REHAB-HF) trial: design and rationale
Circ Hear Fail Kheirbek 8 4 733 2015 10.1161/CIRCHEARTFAILURE.115.002153 Discharge hospice referral and lower 30-day all-cause readmission in medicare beneficiaries hospitalized for heart failure
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.